Lucid Diagnostics Inc. ( (LUCD) ) has released its Q3 earnings. Here is a breakdown of the information Lucid Diagnostics Inc. presented to its ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Australia is on the brink of a healthcare revolution driven by DNA science that will save lives and prevent disease – but top ...

Genetic technology in medicine has evolved to the point where it is now being used to improve care and outcomes for ...

Because 23andMe is not a medical company, customers' personal information is not protected ... s a general rule, consumers ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Plus, Donald Trump is set to visit the White House to meet with President Joe Biden for a symbolic meeting to signify a ...

Reseachers from WEHI (Melbourne, Australia) have found a new way to predict a subset of patients who are likely to become ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.